Increases in TGF-β1 levels in the serum were found in SSc in the early stage against SSc in the late stage by ELISA (30.03 ±4.59 ng/mL vs 13.08 ± 4.50 ng/mL, P = 0.017). This evidence concerns the gene TGFB1 and systemic sclerosis.